We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
+2.01%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$346M
AUM Growth
-$44.9M
Cap. Flow
-$52.1M
Cap. Flow %
-15.05%
Top 10 Hldgs %
39.53%
Holding
62
New
17
Increased
1
Reduced
39
Closed
4

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$8.41M
2
PKG icon
Packaging Corp of America
PKG
+$7.58M
3
MCD icon
McDonald's
MCD
+$5.42M
4
T icon
AT&T
T
+$4.99M
5
K
Kellanova
K
+$4.89M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.36%
2 Financials 14.96%
3 Energy 12.48%
4 Industrials 11.08%
5 Healthcare 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAH icon
51
Cardinal Health
CAH
$54.7B
$501K 0.14%
+6,200
New +$490K
EFA icon
52
iShares MSCI EAFE ETF
EFA
$79.3B
$498K 0.14%
8,182
-2,267
-22% -$142K
SRE icon
53
Sempra
SRE
$56.6B
$498K 0.14%
+8,942
New +$487K
IJH icon
54
iShares Core S&P Mid-Cap ETF
IJH
$126B
$411K 0.12%
14,175
-3,835
-21% -$108K
IJR icon
55
iShares Core S&P Small-Cap ETF
IJR
$113B
$388K 0.11%
6,802
-1,248
-16% -$68.1K
PH icon
56
Parker-Hannifin
PH
$125B
$361K 0.1%
2,800
+14
+0.5% +$1.72K
AGG icon
57
iShares Core US Aggregate Bond ETF
AGG
$138B
$333K 0.1%
3,028
-1,864
-38% -$205K
MDY icon
58
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
$235K 0.07%
890
BSV icon
59
Vanguard Short-Term Bond ETF
BSV
$44.6B
-2,708
Closed -$217K
GSK icon
60
GSK
GSK
$103B
-146,291
Closed -$8.41M
K
61
DELISTED
Kellanova
K
-84,598
Closed -$4.89M
T icon
62
AT&T
T
$160B
-187,493
Closed -$4.99M

Similar funds

Brookmont Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Brookmont Capital Management held 62 positions worth $346M, down 11% from $391M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Brookmont Capital Management withdrew a net $52.1M in Q4 2014, closing 4 positions and reducing 39 holdings. Its most notable exit was GSK, an estimated $8.41M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 16% a quarter earlier, followed by Financials and Energy.

Against the trend, Brookmont Capital Management opened a new position in LyondellBasell Industries worth $7.65M.

  • Brookmont Capital Management's largest Q4 2014 buy was LyondellBasell Industries: 96,368 shares worth $7.65M.
  • Brookmont Capital Management added most to Parker-Hannifin in Q4 2014, an estimated $1.72K increase.
  • Brookmont Capital Management's biggest Q4 2014 reduction was Packaging Corp of America, cutting an estimated $7.58M.
  • Brookmont Capital Management fully exited GSK in Q4 2014, selling an estimated $8.41M.
  • Brookmont Capital Management's ten largest holdings make up 40% of its $346M portfolio in Q4 2014.
  • Brookmont Capital Management opened 17 new positions and closed 4 in Q4 2014.
  • Brookmont Capital Management's portfolio value fell 11% quarter-over-quarter to $346M.

Based on Brookmont Capital Management's 13F filing for Q4 2014, filed 30 Jan 2015.